75000 - Document - Document and Entity Information
link:presentationLink
link:calculationLink
link:definitionLink
75010 - Statement - CONSOLIDATED BALANCE SHEETS
link:presentationLink
link:calculationLink
link:definitionLink
75020 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
75030 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
link:presentationLink
link:calculationLink
link:definitionLink
75040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (PARENTHETICAL)
link:presentationLink
link:calculationLink
link:definitionLink
75050 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
link:presentationLink
link:calculationLink
link:definitionLink
75060 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS
link:presentationLink
link:calculationLink
link:definitionLink
995455 - Disclosure - Cybersecurity Risk Management, Strategy, and Governance
link:presentationLink
link:calculationLink
link:definitionLink
995465 - Disclosure - Nature of the Business and Basis of Presentation
link:presentationLink
link:calculationLink
link:definitionLink
995475 - Disclosure - Summary of Significant Accounting Policies
link:presentationLink
link:calculationLink
link:definitionLink
995495 - Disclosure - Fair Value Measurements
link:presentationLink
link:calculationLink
link:definitionLink
995505 - Disclosure - Inventory
link:presentationLink
link:calculationLink
link:definitionLink
995515 - Disclosure - Prepaid Expenses and Other Current Assets
link:presentationLink
link:calculationLink
link:definitionLink
995525 - Disclosure - Accrued Expenses
link:presentationLink
link:calculationLink
link:definitionLink
995535 - Disclosure - License and Collaboration Agreements
link:presentationLink
link:calculationLink
link:definitionLink
995545 - Disclosure - Population Health Partners
link:presentationLink
link:calculationLink
link:definitionLink
995555 - Disclosure - Commitments and Contingencies
link:presentationLink
link:calculationLink
link:definitionLink
995565 - Disclosure - Convertible Preferred Stock
link:presentationLink
link:calculationLink
link:definitionLink
995575 - Disclosure - Common Stock
link:presentationLink
link:calculationLink
link:definitionLink
995585 - Disclosure - Stock-Based Compensation
link:presentationLink
link:calculationLink
link:definitionLink
995595 - Disclosure - Income Taxes
link:presentationLink
link:calculationLink
link:definitionLink
995605 - Disclosure - Defined Contribution Plan
link:presentationLink
link:calculationLink
link:definitionLink
995615 - Disclosure - Net Loss per Share
link:presentationLink
link:calculationLink
link:definitionLink
995625 - Disclosure - Related Party Transactions
link:presentationLink
link:calculationLink
link:definitionLink
995635 - Disclosure - Segment Reporting
link:presentationLink
link:calculationLink
link:definitionLink
995645 - Disclosure - Selected Quarterly Financial Data (unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
995655 - Disclosure - Subsequent Events
link:presentationLink
link:calculationLink
link:definitionLink
995665 - Disclosure - Subsequent Events (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
995675 - Disclosure - Summary of Significant Accounting Policies (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
995685 - Disclosure - Summary of Significant Accounting Policies (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995705 - Disclosure - Fair Value Measurements (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995715 - Disclosure - Inventory (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995725 - Disclosure - Prepaid Expenses and Other Current Assets (Table)
link:presentationLink
link:calculationLink
link:definitionLink
995735 - Disclosure - Accrued Expenses (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995745 - Disclosure - Commitments and Contingencies (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995755 - Disclosure - Convertible Preferred Stock (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995765 - Disclosure - Stock-Based Compensation (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995775 - Disclosure - Income Taxes (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995785 - Disclosure - Net Loss per Share (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995795 - Disclosure - Selected Quarterly Financial Data (unaudited) (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995805 - Disclosure - Segment Reporting (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995815 - Disclosure - Nature of the Business and Basis of Presentation - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995825 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995835 - Disclosure - Summary of Significant Accounting Policies - Summary of Consolidated Total Gross Revenue (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995845 - Disclosure - Summary of Significant Accounting Policies - Summary of Consolidated Total Gross Revenue (Parenthetical) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995855 - Disclosure - Summary of Significant Accounting Policies - Summary of Estimated Useful Life of Property and Equipment (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995885 - Disclosure - Fair Value Measurments - Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995895 - Disclosure - Fair Value Measurements (Additional Information) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995905 - Disclosure - Inventory (Additional Information) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995915 - Disclosure - Inventory - Schedule Of Presents Inventories (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995925 - Disclosure - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995935 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995945 - Disclosure - License and Collaboration Agreements - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995955 - Disclosure - Population Health Partners (Additional Information) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995965 - Disclosure - Commitments and Contingencies - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995975 - Disclosure - Commitments and Contingencies - Schedule of operating lease expense (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995985 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Payments Under Non-cancellable Purchase Obligations (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995995 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Payments Under Non-cancellable Purchase Obligations (Details) 2
link:presentationLink
link:calculationLink
link:definitionLink
996005 - Disclosure - Common Stock - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996015 - Disclosure - Stock-Based Compensation - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996025 - Disclosure - Stock-Based Compensation - Schedule of Weighted Average Fair Values and Valuation Assumptions (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996035 - Disclosure - Stock-Based Compensation - Summary of Stock Options Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996045 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Unit Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996055 - Disclosure - Stock-Based Compensation - Summary of Share Based Compensation Expense Recognized (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996065 - Disclosure - Income Taxes - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996075 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996085 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate (Details) 2
link:presentationLink
link:calculationLink
link:definitionLink
996095 - Disclosure - Income Taxes - Summary of Net Deferred Tax Assets (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996105 - Disclosure - Income Taxes - Summary of Change in Valuation Allowance (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996115 - Disclosure - Defined Contribution Plan - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996125 - Disclosure - Net Loss per Share (Additional Information) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996135 - Disclosure - Net Loss per Share - Schedule of Earning Per Share, Basic and Diluted (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996145 - Disclosure - Net Loss per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996155 - Disclosure - Related Party Transactions - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996165 - Disclosure - Selected Quarterly Financial Data (unaudited) - Schedule of Quarterly Financial Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996175 - Disclosure - Segment Reporting - Schedule of Segment Reported Segment Revenues, and Significant Segment Expenses (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996185 - Disclosure - Segment Reporting - Schedule of Segment Reported Segment Revenues, and Significant Segment Expenses (Parenthetical) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
Subsequent Events (Unaudited)
Subsequent Events Unaudited [Text Block]
Subsequent events (unaudited).
Weighted Average Grant Date Fair Value Vested
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Deferred offering costs in accrued expenses
Deferred offering costs in accrued expenses
Deferred offering costs in accrued expenses
Other Research and Development Expense
Recognized research and development
Term B Loan [Member]
Term B Loan [Member]
Term B Loan [Member]
Accrued employee compensation
Accrued Employee Benefits, Current
Concentration Risk Type [Axis]
Research development and regulatory milestone.
Research Development And Regulatory Milestone [Member]
Research Development And Regulatory Milestone
Deferred tax assets:
Deferred Tax Assets, Gross [Abstract]
Number of quarterly installments for vesting succeeding period
Share Based Compensation Arrangement By Share Based Payment Award Vesting Number Of Quarterly Installment Succeeding Period
Share based compensation arrangement by share based payment award vesting number of quarterly installment succeeding period.
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Preferred Stock, Shares Issued
Preferred Stock, Shares Issued, Total
Preferred stock shares issued
Statement of Financial Position Location, Balance [Domain]
Adimab Platform Transfer Agreement [Member]
Adimab Platform Transfer Agreement [Member]
Adimab Platform Transfer Agreement [Member]
Asset and Liabilities Measured at Fair Value on Recurring Basis
Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]
Accounts payable
Increase (Decrease) in Accounts Payable
Increase (Decrease) in Accounts Payable, Total
Plan Name
Plan Name [Axis]
Available-for-sale securities held, remaining maturities greater than twelve months
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer
Equity [Abstract]
Payments For Tenant Improvements
Payments for Tenant Improvements
Entity Current Reporting Status
Entity Current Reporting Status
Other Commitment
Aggregate fee, Total
Aggregate fee
Up-Front Payment
Up-Front Payment
Up-front payment
Operating expenses:
Operating Expenses [Abstract]
Research Development Foundation License Agreement [Member]
Research Development Foundation License Agreement [Member]
Research Development Foundation License Agreement [Member]
Fair Value Level 2
Fair Value, Inputs, Level 2 [Member]
Deferred Tax Assets, Net of Valuation Allowance
Total deferred tax assets
Commitments and Contingencies Disclosure [Text Block]
Commitments and Contingencies
Common stock, shares authorized
Common Stock, Shares Authorized
Convertible preferred stock, par value (in dollars per share)
Temporary Equity, Par or Stated Value Per Share
PHP Warrants [Member]
PHP Warrants Outstanding [Member]
PHP Warrants Outstanding [Member]
Fair Value
Fair Value
Assets, Fair Value Adjustment
Product and Service
Product and Service [Axis]
Agency Securities [Member]
Document Fiscal Period Focus
Document Fiscal Period Focus
Stated interest rate
Debt Instrument, Interest Rate, Stated Percentage
Entity Shell Company
Entity Shell Company
Convertible preferred stock, shares outstanding
Temporary Equity, Shares Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueGrantdatefairvalueperwarrant
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueGrantdatefairvalueperwarrant
Grant date fair value per warrant
Segment Information
Segment Reporting, Policy [Policy Text Block]
Cash and cash equivalents
Cash and Cash Equivalent
Cash and Cash Equivalents, at Carrying Value, Total
Cash and Cash Equivalents, at Carrying Value, Beginning Balance
Cash and Cash Equivalents, at Carrying Value, Ending Balance
Milestone payment.
Milestone Payment
Milestone payment
Receivable Type [Axis]
Cybersecurity Risk Management, Strategy, and Governance [Abstract]
Common stock, shares issued
Common Stock, Shares, Issued
Common Stock, Shares, Issued, Total
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]
Accrued Inventory
Accrued Inventory
Accrued inventory
Cybersecurity Risk Board of Directors Oversight [Text Block]
Two Thousand And Twenty Two Shelf Registration Statement [Member]
Two Thousand And Twenty Two Shelf Registration Statement [Member]
2022 Shelf Registration Statement [Member]
Asset Class [Domain]
Statement [Table]
Statement [Table]
2020 Equity Incentive Plan [Member]
Equity incentive plan.
Equity Incentive Plan [Member]
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Operating lease right-of-use asset recognized upon adoption of ASC 842
Long-Term Purchase Commitment, Category of Item Purchased [Domain]
Two Thousand And Twenty Two Employee Stock Purchase Plan [Member]
Two Thousand And Twenty Two Employee Stock Purchase Plan [Member]
2022 Employee Stock Purchase Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Fair value of common stock
Statement [Line Items]
Statement [Line Items]
Warrant [Member]
PHP Warrant
Entity Filer Category
Entity Filer Category
Effect of exchange rate changes on cash and cash equivalents
Effect Of Exchange Rate Changes On Cash And Cash Equivalents
Effect Of Exchange Rate Changes On Cash And Cash Equivalents
Liabilities and Equity
Total liabilities and stockholders' equity
Term A Loan [Member]
Term A Loan Member
Term A Loan [Member]
Amortized Cost
Amortization
Amortization, Total
Options exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Long-Lived Tangible Asset [Axis]
Valuation allowance
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Increase (decrease) for the current period
Operating Loss Carryforwards [Table]
Operating Loss Carryforwards [Table]
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]
Valuation allowance
Deferred Tax Assets, Valuation Allowance
Deferred Tax Assets, Valuation Allowance, Total
Valuation allowance at the end of the year
Valuation allowance at the beginning of the year
Federal statutory income tax rate
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent
Federal statutory income tax rate
Cybersecurity Risk Management Third Party Engaged [Flag]
Documents Incorporated by Reference
Documents Incorporated by Reference [Text Block]
Fund Allotate For Prospectus Supplement
Fund Allotate For Prospectus Supplement
Allocated fund for Prospectus Supplement
Other Noncash Income (Expense)
Other Noncash Income (Expense), Total
Other non-cash adjustments
Acquired in-process research and development
Acquired In Process Research And Development
Acquired in-process research and development.
Effective income tax rate
Effective Income Tax Rate Reconciliation, Percent
Stock Options [Member]
Cost of Product Revenue [Member]
Cost of Product Revenue [Member]
Cost Of Product Revenue [Member]
Classification and Accretion of Convertible Preferred Stock
Classification And Accretion Of Convertible Preferred Stock Policy [Text Block]
Classification and Accretion of Convertible Preferred Stock.
Income Tax Jurisdiction [Axis]
Income Tax Authority
Geographical [Domain]
Inventory, Finished Goods, Gross
Finished goods
Pre-funded Warrants
Pre Funded Warrants Policy Text Block
Pre Funded Warrants Policy Text Block
Common shares repurchased
Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited
Schedule of Inventory, Current [Table Text Block]
Schedule of Inventory
Tax Year2040
Tax Year2040 [Member]
Identified as tax year 2040.
Additional paid-in capital
Additional Paid in Capital, Common Stock
Additional Paid in Capital, Common Stock, Beginning Balance
Additional Paid in Capital, Common Stock, Ending Balance
Exercise of stock options
Exercise of stock options
Exercise of stock options
Defined Contribution Plan
Defined Contribution Plan [Text Block]
Summary of Significant Accounting Policies
Significant Accounting Policies [Text Block]
Property, Plant and Equipment [Line Items]
Concentration Risk [Table]
Granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Granted
Wu Xi Commercial Manufacturing Services Agreement.
Wu Xi Commercial Manufacturing Services Agreement [Member]
WuXi Commercial Manufacturing Services Agreement [Member]
Cybersecurity Risk Management, Strategy, and Governance [Table]
Schedule of Earnings Per Share, Basic and Diluted
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Earnings Per Share, Basic
Net loss per share attributable to common stockholders, basic and diluted
Net loss per share attributable to common stockholders, basic
Prepaid Compensation And Related Expenses
Prepaid compensation and related expenses
Prepaid compensation and other
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Number of Shares Beginning Balance
Number of Shares Ending Balance
Interest Income (Expense), Nonoperating
Interest Income (Expense), Nonoperating, Total
Total revenue
Pemivibart Research and Development Expense
Amount of expense for research and development allocated to the Pemivibart program.
Pemivibart
Total current liabilities
Liabilities, Current
Property Plant And Equipment Estimated Useful Lives
Property Plant And Equipment Estimated Useful Lives1
Property Plant And Equipment Estimated Useful Lives1
Increase (Decrease) in Accounts Receivable
Accounts receivable
Accounts receivable
Adjustments to reconcile net loss to net cash used in operating activities:
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]
Effective Income Tax Rate Reconciliation, Cross-Border, Other, Amount
Foreign tax effects, Other, Amount
Fair value of common stock
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price
Accrued Upfront Fee.
Accrued Upfront Fee
Accrued Upfront Fee
Domestic Tax Authority
Domestic Tax Jurisdiction [Member]
2027
Purchase Obligation, to be Paid, Year Two
Effective Income Tax Rate Reconciliation, Tax Credit, Percent [Abstract]
Tax credits
Final Payment Fee Percentage
Final Payment Fee Percentage
Final payment fee
Stockholders' equity (deficit):
Stockholders’ deficit:
Equity, Attributable to Parent [Abstract]
Entity Small Business
Entity Small Business
Term facility
Line of Credit Facility, Commitment Fee Amount
Increase (Decrease) in Accrued Liabilities, Total
Accrued expenses
Increase (Decrease) in Accrued Liabilities
Accumulated Deficit
Accumulated deficit
Retained Earnings (Accumulated Deficit)
Retained Earnings (Accumulated Deficit), Total
Retained Earnings (Accumulated Deficit), Beginning Balance
Retained Earnings (Accumulated Deficit), Ending Balance
Stock-based compensation expense
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost
Other Commitments [Abstract]
Indefinite Period
Indefinite Period [Member]
Indefinite period.
Available For Sale Debt Securities [Member]
Available For Sale Debt Securities [Member]
Available For Sale Debt Securities [Member]
Unallocated research and development expenses
Unallocated research and development expenses
Unallocated research and development expenses
Preferred Stock [Member]
Two Thousand And Twenty One Employee Stock Purchase Plan
Two Thousand And Twenty One Employee Stock Purchase Plan [Member]
Two Thousand And Twenty One Employee Stock Purchase Plan Member
2021 Employee Stock Purchase Plan [Member]
Unrealized Gains
Unrealized Gain on Marketable Securities
Unrealized Gain on Marketable Securities
Entity Well-known Seasoned Issuer
Entity Well-known Seasoned Issuer
Forfeited
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Proceeds from underwritten public offering, net of underwriting discounts and commissions
Proceeds from Issuance Initial Public Offering
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value
Intrinsic value of stock options exercised
Common stock issued in connection with at-the-market offering, net
Common Stock Issued in Connection With At-the-market Offering
Common Stock Issued in Connection With At-the-market Offering
Base Rent Charges
Base Rent Charges
Base rent charges
Operating lease liabilities
Deferred tax assets Operating lease liability
Deferred tax assets Operating lease liability
Legal Costs, Policy [Policy Text Block]
Patent Costs
WuXi Cell Line License Agreement.
Wu Xi Cell Line License Agreement [Member]
Cell Line License Agreement [Member]
Summary of Estimated Useful Life of Property and Equipment
Estimated Useful Life of Property and Equipment [Table text block ]
Estimated Useful Life of Property and Equipment.
Cost, Depreciation and Amortization
Cost, Depreciation and Amortization, Total
Depreciation and amortization expense
Other Current Assets [Member]
Stock-Based Compensation
Share-Based Payment Arrangement [Text Block]
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Distributors Accounted Accounts Receivable
Distributors Accounted Accounts Receivable
Third-party specialty distributors accounted accounts receivable
Defined Contribution Plan [Table]
Weighted-average remaining contractual term (Years)
Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term
Payments for at-the-market offering costs
Payments For At The Market Offering Costs
Payments For At The Market Offering Costs
Amendment Flag
Amendment Flag
Product and Service [Domain]
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
U.S. Federal Taxes at statutory rate, Amount
U.S. federal taxes at statutory rate, Amount
Due from Related Party
Due From Related Party
Due From Related Party
Inventory Disclosure [Text Block]
Inventory
Convertible preferred stock shares reserved for future issuance
Convertible Preferred Stock, Shares Reserved for Future Issuance
Chief Executive Officer [Member]
Chief Executive Officer [Member]
Net Loss per Share
Earnings Per Share, Policy [Policy Text Block]
Concentration Risk [Line Items]
Liabilities and Equity [Abstract]
Liabilities and Stockholders' Equity
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Optimization Completion Fee.
Optimization Completion Fee
Optimization completion fee payable to related party
Accounts Receivable, net
Accounts Receivable [Policy Text Block]
Net cash used in operating activities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Increase (Decrease) in Operating Lease Liability
Operating lease liabilities
Adimab [Member]
Adimab [Member]
Adimab [Member]
Common Stock [Member]
Common Stock [Member]
Subordinated Borrowing, Interest Rate
Borrowing rate
Cybersecurity Risk Role of Management [Text Block]
Tax credit carryforward
Tax Credit Carryforward, Amount
Granted
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Granted
Interest Receivable, Current
Interest receivable
Product Revenue, Net
Product Revenue Net Policy Text Block
Product Revenue Net Policy Text Block
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCommonsharesoutstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCommonsharesoutstanding
Common shares outstanding
Entity Address, Address Line One
Entity Address, Address Line One
Total deferred tax liabilities
Deferred Tax Liabilities, Gross
Total deferred tax liabilities
Total deferred tax liabilities
Schedule of Weighted Average Fair Values and Valuation Assumptions
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Dividends Payable [Table]
Fair Value Hierarchy and NAV
Fair Value Hierarchy and NAV [Axis]
Earnings Per Share [Abstract]
Income Taxes
Income Tax, Policy [Policy Text Block]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]
Supplemental Cash Flow Information [Abstract]
Supplemental disclosure of cash flow information:
Series C convertible preferred stock.
Series C Convertible Preferred Stock [Member]
November 15, 2028 [Member]
Fifteen November Two Thousand Twenty Eight Member
Fifteen November Two Thousand Twenty Eight [Member]
Acquired in-process research and development expense.
Acquired In Process Research And Development Expense
Acquired in-process research and development
Statement of Financial Position Location, Balance [Axis]
Operating lease right-of-use assets
Operating Lease, Right-of-Use Asset
Deferred Tax Assets, Gross
Total gross deferred tax assets
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]
Inventory Disclosure [Abstract]
Common Stock Issued in Connection With Public Offering, Share
Common Stock Issued in Connection With Public Offering, Share
Common stock issued in connection with public offering, Share
Class of Warrant or Right [Axis]
Document Type
Document Type
Entity Central Index Key
Entity Central Index Key
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]
Net increase (decrease) in cash and cash equivalents
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Subsequent Event Type [Domain]
Fair Value Adjustment of Warrants
Warrant expense
Warrant expense
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Warrants to Purchase Common Stock [Member]
Warrants to Purchase Common Stock [Member]
Warrants to Purchase Common Stock [Member]
Common stock, par value
Common Stock, Par or Stated Value Per Share
2020 Employee Stock Purchase Plan Member
Two Thousand And Twenty Employee Stock Purchase Plan
Two Thousand And Twenty Employee Stock Purchase Plan Member
Deferred Offering Costs In Accounts Payable
Deferred Offering Costs In Accounts Payable
Deferred offering costs in accounts payable
ATM Facility [Member]
ATM Facility [Member]
Tax credit carryforward expiration term
Tax Credit Carryforward Expiration Term
Description of tax credit cexpiration term.
Security Deposit
Security Deposit
Operating Lease, Right-of-Use Asset, Periodic Reduction
Amortization of operating lease right-of-use assets
Weighted Average Remaining Contractual Term
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Weighted Average Remaining Contractual Term
Defined Contribution Plan Disclosure [Line Items]
Components of Deferred Tax Assets and Liabilities [Abstract]
Debt securities, available-for-sale
Debt Securities, Available-for-Sale
Debt Securities, Available-for-Sale, Total
Property and equipment included in accrued expenses
Property and equipment included in accrued expenses
Property and equipment included in accrued expenses
Ownership Change Description
A description of ownership change.
Description of ownership change
Realized gains or losses on marketable securities recognized
Realized Investment Gains (Losses)
Realized Investment Gains (Losses), Total
Document Financial Statement Error Correction Flag
Document Financial Statement Error Correction [Flag]
Exercised
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Common stock, option Exercised
Exercise of stock options, shares
Finished goods inventory, current
Finished Goods Inventory Current
Finished Goods Inventory Current
Specialty Distributor 3
Specialty Distributor Three [Member]
Specialty Distributor Three [Member]
Accrued expenses
Accrued Liabilities, Current
Accrued Liabilities, Current, Total
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Current Fiscal Year End Date
Current Fiscal Year End Date
Grant exercise price, percentage of estimated fair value of common stock on date of grant (not less than)
Share Based Compensation Arrangement By Share Based Payment Award Options Exercise Price Percentage Of Fair Value Of Common Stock
Share based compensation arrangement by share based payment award options exercise price percentage of fair value of common stock.
Other
Other Accrued Liabilities
Distributer Three [Member]
Distributer Three [Member]
Distributer 3
Entity Address, State or Province
Entity Address, State or Province
Related-Party Amounts
Related-Party Amounts
Related-party amounts
Preferred Stock, Shares Outstanding, Beginning Balance
Preferred Stock, Shares Outstanding, Ending Balance
Preferred Stock, Shares Outstanding
Preferred stock shares outstanding
Comprehensive loss
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Research and Development Expenses
Research and Development Expense, Policy [Policy Text Block]
Class of Warrant or Right [Domain]
Inventory [Axis]
Geographical [Axis]
Deferred Tax Assets Warrant Expense
Deferred Tax Assets Warrant Expense
Warrant expense
Deferred tax liabilities Operating lease right-of-use assets
Deferred tax liabilities Operating lease right-of-use assets
Operating lease right-of-use assets
Payments for Royalties
Payments For Royalties
Summary of Share Based Compensation Expense Recognized
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
Nontaxable or nondeductible items, Other, Amount
Comprehensive Loss
Comprehensive Income, Policy [Policy Text Block]
Summary of Net Deferred Tax Assets
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
License and Collaboration Agreements
Collaborative Arrangement Disclosure [Text Block]
Issuance of Common Stock Upon Restricted Stock Units ("RSU") Vesting, Share
Issuance of Common Stock Upon Restricted Stock Units ("RSU") Vesting, Share
Issuance of common stock upon restricted stock units vesting, Share
Subsequent Event [Member]
Subsequent Event [Member]
Marketable Securities, Policy [Policy Text Block]
Marketable Securities
Deferred offering and issuance cost included in accrued expenses
Deferred offering and issuance cost included in accrued expenses
Deferred offering costs in accrued expenses
AccruedResearchandDevelopmentCostsPolicyTextBlock
AccruedResearchandDevelopmentCostsPolicyTextBlock
Accrued Research and Development Costs
Other non-current assets
Other Assets, Noncurrent
Other Assets, Noncurrent, Total
Antidilutive Securities
Antidilutive Securities [Axis]
Asset Acquisitions and Acquired In-Process Research and Development Expenses
Asset Acquisitions And Acquired In Process Research And Development Expenses Policy [Text Block]
Asset Acquisitions and Acquired In-Process Research and Development Expenses.
Operating Loss Carryforwards [Line Items]
Operating Loss Carryforwards [Line Items]
Percentage of options vesting
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage
Aggregate Intrinsic Value, Vested and Expected to vest
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
State and Local Jurisdiction
State and Local Jurisdiction [Member]
Related Party Transaction [Axis]
Accumulated Other Comprehensive Loss [Member]
AOCI Attributable to Parent [Member]
Quarterly Fee
Quarterly Fee.
Quarterly fee
Finite-Lived Intangible Assets, Major Class Name
Finite-Lived Intangible Assets, Major Class Name [Domain]
Treasury Stock, Common, Shares
Treasury Stock, Common, Shares
Treasury Stock, Common, Shares
Treasury Stock, Common, Shares
Cash and Cash Equivalents
Cash and Cash Equivalents [Domain]
Preferred stock (undesignated), $0.0001 par value; 10,000,000 shares authorized and no shares issued and outstanding at December 31, 2025 and December 31, 2024
Preferred Stock, Value, Issued
Preferred Stock, Value, Issued, Ending Balance
Preferred Stock, Value, Issued, Beginning Balance
Preferred Stock, Value, Issued, Total
Total selling, general and administrative expenses
Selling, general and administrative
Selling, General and Administrative Expense
2023 ATM Prospectus Supplement
Two Thousand And Twenty Three ATM Prospectus Supplement [Member]
Two Thousand And Twenty Three ATM Prospectus Supplement [Member]
Other income, net
Other Nonoperating Gains (Losses)
Distributer 1
Distributer One [Member]
Distributer One [Member]
Minimum [Member]
Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value Granted
Financial Instrument [Axis]
Current assets:
Assets, Current [Abstract]
Selected Quarterly Financial Data (unaudited)
Quarterly Financial Information [Text Block]
Fair Value Level 3
Fair Value, Inputs, Level 3 [Member]
Series A Convertible Preferred Stock [Member]
Series A Convertible Preferred Stock [Member]
Series A convertible preferred stock.
Segment Reporting [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis
Tax Period
Tax Period [Domain]
Current liabilities:
Liabilities, Current [Abstract]
Product [Member]
Product revenue
Related Party Transactions [Abstract]
Balances, shares
Balance, shares
Shares, Outstanding
Operating loss carryforwards
Operating Loss Carryforwards
Operating Loss Carryforwards, Total
Accounts receivable, net
Accounts Receivable, after Allowance for Credit Loss, Current
Accounts Receivable, after Allowance for Credit Loss, Current, Total
Lessee, Operating Lease, Renewal Term
Lease term
PHP Member
PHP Member
PHP (member)
Commitments and contingencies (Note 9)
Commitments and Contingencies
Leases
Lessee, Leases [Policy Text Block]
Work in process
Inventory, Work in Process, Gross
General and Administrative Expense [Member]
Selling, General and Administrative [Member]
General and Administrative Expense
Operating Lease, Liability
Operating cash flows related to operating leases
Operating cash flows related to operating leases
Auditor Firm ID
Debt Instrument, Basis Spread on Variable Rate
Spread on variable rate
Accounts Receivable, before Allowance for Credit Loss, Current
Accounts Receivable
Second Product.
Second Product [Member]
Second Product [Member]
Accrued Liabilities [Abstract]
Costs of Revenue
The aggregate costs of goods produced and sold and services rendered during the reporting period.
Cost of product revenue
Concentration Risk Benchmark [Axis]
Category of Item Purchased [Axis]
Number of quarterly installments for vesting
Share Based Compensation Arrangement By Share Based Payment Award Vesting Number Of Quarterly Installment
Share based compensation arrangement by share based payment award vesting number of quarterly installment.
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent
Changes in valuation allowances
Allowance for doubtful accounts
Allowance for Doubtful Accounts, Premiums and Other Receivables
Net loss
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total
Common stock issued in connection with at-the-market offering, net, Share
Common Stock Issued in connection with At-the-market Offering, Share
Common Stock Issued in connection with At-the-market Offering, Share
Share-Based Payment Arrangement, Recognized Amount [Abstract]
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]
Weighted Average Number of Shares Outstanding
Weighted Average Number of Shares Outstanding, Basic
Weighted Average Number of Shares Outstanding, Basic, Total
Weighted-average common shares outstanding, basic
Scenario [Axis]
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Aggregate Intrinsic Value, Exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
Increase (Decrease) in Other Current Liabilities
Other current liabilities
Terminate Agreement Notice Period
Terminate Agreement Notice Period
Notice period of termination
Schedule of Effective Income Tax Rate
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Long-Lived Tangible Asset [Domain]
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]
Deposit Liabilities, Other, Average Rate Paid
Deposit Rate reduced
Subsequent Events
Subsequent Events [Text Block]
Federal research and development tax credits
Effective Income Tax Rate Reconciliation, Tax Credit, Percent
Effective Income Tax Rate Reconciliation, Tax Credit, Percent, Total
Federal research and development tax credits
Related Party Transactions
Related Party Transactions Disclosure [Text Block]
Royalty, Percentage of Sublicense Consideration.
Royalty Percentage Of Sublicense Consideration
Royalty percentage of sublicense consideration
Stock-based compensation expense
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total
Potential milestone payment.
Potential Milestone Payment
Potential milestone payment
Incremental Annual Base Rent
Incremental Annual Base Rent
Incremental annual base rent
Prepaid Expenses Other Current Assets
Prepaid Expenses Other Current Assets [Text Block]
The entire disclosure for prepaid expenses and other current assets.
Research and development tax credit carryforwards
Deferred Tax Asset, In-Process Research and Development
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount
Changes in valuation allowances, Amount
Balance
Balance
Equity, Attributable to Parent
Total stockholders' equity
Preferred stock, par value
Preferred stock per share
Preferred Stock, Par or Stated Value Per Share
Statement of Stockholders' Equity [Abstract]
Minimum Lease Payments, Sale Leaseback Transactions
Total future minimum lease payments
Series A Preferred Stock [Member]
Series A Preferred Stock [Member]
Use of Estimates
Use of Estimates, Policy [Policy Text Block]
Schedule of Unvested Common Stock Options
Schedule of Nonvested Share Activity [Table Text Block]
Unaudited Interim Financial Information
Credit Loss, Financial Instrument [Policy Text Block]
Treasury Stock, Common [Member]
DeferredOfferingCostsPolicyTextBlock
DeferredOfferingCostsPolicyTextBlock
Deferred Offering Costs
Leasehold Improvements [Member]
Leasehold Improvements [Member]
Entity Address, Address Line Two
Entity Address, Address Line Two
Fair Value Measurements
Fair Value Disclosures [Text Block]
Third Party Logistic distributors accounted gross sales
Third Party Logistic Distributors Accounted Gross Sales
Third Party Logistic Distributors Accounted Gross Sales
VYD2311 Research and Development Expense
Amount of expense for research and development allocated to the VYD2311 program
VYD2311
US
UNITED STATES
Fair value transfers between levels transfers amount.
Fair Value Transfers Between Levels Transfers Amount
Transfers between level 3
Sales Agreement [Member]
Sales Agreement [Member]
Sales Agreement [Member]
Schedule of Accrued Liabilities [Table Text Block]
Schedule of Accrued Expenses
Debt Instrument, Name [Domain]
Noncash Investing and Financing Items [Abstract]
Supplemental disclosure of non-cash investing activities:
Inventory, Current [Table]
Debt Instrument, Periodic Payment, Total
Up-Front Payment
Debt Instrument, Periodic Payment
Inventory
Inventory, Net, Total
Inventory, Noncurrent
In Process Research and Development [Member]
In Process Research and Development [Member]
Plan Name
Plan Name [Domain]
Two Thousand TwentySix Inducement Plan [Member]
Two Thousand TwentySix Inducement Plan [Member]
2026 Inducement Plan
Unrealized loss, net of tax
Unrealized gain (Loss) on available-for-sale securities, net of tax
Unrealized gain (Loss) on available-for-sale securities, net of tax
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Adimab Collaboration Agreement [Member]
Adimab Collaboration Agreement [Member]
Adimab Collaboration Agreement.
Population Health Partners
Other Commitment Disclosure [Text Block]
Other Commitment Disclosure [Text Block]
Credit Facility [Axis]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]
Impairment loss
Impairment, Long-Lived Asset, Held-for-Use
Impairment, Long-Lived Asset, Held-for-Use, Total
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]
Shelf Registration Statement [Member]
Shelf Registration Statement [Member]
Present value of operating lease liability
Present value of operating lease liability
Present value of operating lease liability
Class of Warrant or Right, Outstanding
Exercisable common stock
Beginning Balance
Ending Balance
Tax Period
Tax Period [Axis]
Treasury stock
Treasury stock
Treasury Stock, Value
Treasury Stock, Value, Total
Treasury stock, at cost; 0 shares and 468,751 shares at December 31, 2022 and December 31, 2021, respectively
Related Party
Related and Nonrelated Parties [Axis]
License Agreement [Abstract]
License Agreement Abstract.
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
Other adjustments, Amount
Other comprehensive income (loss)
Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent [Abstract]
Class of Warrant or Right [Table]
Property and Equipment
Property, Plant and Equipment, Policy [Policy Text Block]
Acquired In Process Research And Development Expense [Member]
Acquired In Process Research And Development Expense [Member]
Entity Address, City or Town
Entity Address, City or Town
Security Exchange Name
Security Exchange Name
Credit Facility [Domain]
Senior Secured Term Loan Facility [Member]
Senior Secured Term Loan Facility [Member]
Senior Secured Term Loan Facility [Member]
Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
Other adjustments
Schedule of Preferred Stock
Temporary Equity [Table Text Block]
Counterparty Name [Axis]
Vested and expected to vest
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Concentration Risk Type [Domain]
First Product.
First Product [Member]
First Product [Member]
Antidilutive Securities, Name
Antidilutive Securities, Name [Domain]
Inventory, Net
Inventory, Net, Total
Inventory, net
Intangibles
Deferred Tax Assets, Goodwill and Intangible Assets
Related Party Transaction Expenses From Transaction With Related Party
Related Party Transaction Expenses From Transaction With Related Party
Related Party Transaction Expenses From Transaction With Related Party
November 15, 2030 [Member]
Fifteen November Two Thousand Thirty [Member]
Fifteen November Two Thousand Thirty [Member]
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Statistical Measurement
Statistical Measurement [Domain]
Fifteen November Two Thousand Twenty Nine [Member]
November 15, 2029 [Member]
Fifteen November Two Thousand Twenty Nine [Member]
Present value adjustment
Present value adjustment
Present value adjustment
Warrant exercise price
Class of Warrant or Right, Exercise Price of Warrants or Rights
Exercise price
Total current assets
Assets, Current
Share-Based Payment Arrangement, Expense
Stock-based compensation
Document Period End Date
Document Period End Date
Title and Position [Axis]
Fair Value Hierarchy and NAV
Fair Value Hierarchy and NAV [Domain]
Defined Contribution Plan, Cost
Defined contribution amount
ICFR Auditor Attestation Flag
ICFR Auditor Attestation Flag
Options exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage
Percentage of eligible participants of non-elective contributions
Statement of Financial Position [Abstract]
Restricted Stock
Restricted Stock Units (RSUs) [Member]
Revenue Recognition
Revenue [Policy Text Block]
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Antidilutive Security, Excluded EPS Calculation [Table]
Class of Stock
Class of Stock [Axis]
Due To Related Parties
Due To Related Parties
Due To Related Parties
Selected Quarterly Financial Information [Abstract]
Cybersecurity Risk Management, Strategy, and Governance [Line Items]
Emerging Growth Company
Emerging Growth Company Policy [Text Block]
Emerging Growth Company
Total liabilities
Liabilities
Operating Costs and Expenses [Abstract]
Operating costs and expenses:
Financial Instruments [Domain]
IPR&D expense.
In Process Research And Development Expense [Member]
IPR&D Expense [Member]
Third Party Specialty Distributors Accounted Gross Sales
Third Party Specialty Distributors Accounted Gross Sales
Third party specialty distributors accounted gross sales
Weighted Average Grant Date Fair Value Outstanding at December 31, 2025
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options vested Weighted Average Grant Date Fair Value
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options vested Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value Outstanding at December 31, 2024
Restricted Stock [Member]
Restricted Stock [Member]
Prepaid Expense and Other Assets, Current [Abstract]
Cash and Cash Equivalent [Table]
Weighted-average common shares outstanding, diluted
Weighted Average Number of Shares Outstanding, Diluted, Total
Weighted Average Number of Shares Outstanding, Diluted
Completion Fee.
Completion Fee
Completion fee
Entity File Number
Securities Act File Number
Cover [Abstract]
Operating Leases, Future Minimum Payments Receivable, Thereafter
2028 and thereafter
Payments for underwritten public offering costs
Payments for Repurchase of Initial Public Offering
Prepaid expenses and other current assets
Prepaid expenses and other current assets
Prepaid Expense and Other Assets, Current
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Forfeited
Common stock, conversion basis
Common Stock, Conversion Basis
Summary of Change in Valuation Allowance
Summary of Valuation Allowance [Table Text Block]
Revenue Benchmark [Member]
Revenue Benchmark
Scenario [Domain]
US Treasury Securities
US Treasury Securities [Member]
Number of shares of common stock authorized for issuance
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized
Unrealized Loses
Unrealized Loss on Marketable Securities
Unrealized loss on marketable securities.
Segment Reporting Disclosure [Text Block]
Segment Reporting
Licensed Product [Member]
Licensed Product [Member]
Licensed Product [Member]
Series B Preferred Stock [Member]
Series B Preferred Stock [Member]
Series B Preferred Stock
Lease Commencement Date
Lease Commencement Date
Lease commencement date
Convertible preferred stock, liquidation preference
Temporary Equity, Liquidation Preference
Other
Deferred Tax Assets, Other
401(k) Plan [Member]
Four Hundred One K Plan Member
Four Hundred One K Plan [Member]
Marketable Securities [Abstract]
Vested and expected to vest
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Property, plant and equipment, useful life
Property, Plant and Equipment, Useful Life
Recently Issued and Adopted Accounting Pronouncements
New Accounting Pronouncements, Policy [Policy Text Block]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent
Nontaxable or nondeductible items, Other
Award vesting period
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period
Sale Leaseback Transaction, Monthly Rental Payments
Monthly rental payments
Common stock, shares outstanding
Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding, Beginning Balance
Common Stock, Shares, Outstanding, Ending Balance
Operating lease liabilities
Operating Lease, Liability, Current
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Percentage deduction of annual taxable income.
Percentage Deduction Of Annual Taxable Income
Percentage deduction of annual taxable income.
Contractual Obligation, Fiscal Year Maturity [Table Text Block]
Schedule of Future Minimum Payments Under Non-cancellable Purchase Obligations
Cybersecurity Risk Management Processes Integrated [Flag]
Document Transition Report
Document Transition Report
Deferred Tax Assets, Net
Total net deferred tax assets
Operating Expenses
Total operating costs and expenses
Oil and Gas, Proved Reserve, Quantity, Royalty Interest Owned, Not Available, Ownership Percentage
Royalty Payment
Research and development expense
Total research and development expenses
Research and development expense
Research and Development Expense
Receivable [Domain]
Inventory Classified In Prepaid And Other Current Assets [Member]
Inventory Classified In Prepaid And Other Current Assets [Member]
Convertible Preferred Stock [Member]
Convertible Preferred Stock [Member]
Specialty Distributor One [Member]
Specialty Distributor One [Member]
Specialty Distributor 1
Statement of Cash Flows [Abstract]
Issuance of common stock
Stock Issued During Period, Value, New Issues
Issuance of common stock, net of issuance costs
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Summary of Stock Option Activity
Assets:
Assets, Fair Value Disclosure [Abstract]
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent
Stock-based compensation
Third Party Logistic Distribution [Member]
Third Party Logistic Distribution [Member]
Third Party Logistic Distribution
Specialty Distributor 2
Specialty Distributor Two [Member]
Specialty Distributor Two [Member]
Equity [Text Block]
Common Stock
Accounts and Financing Receivables [Table]
Deferred Tax Liabilities Depreciation Expense
Deferred Tax Liabilities Depreciation Expense
Depreciation expense
Net Loss per Share
Earnings Per Share [Text Block]
Specified Development And Regulatory Milestones [Member]
Specified Development And Regulatory Milestones [Member]
Specified Development And Regulatory Milestones [Member]
Other segment items expense
Other segment items expense
Other segment items
Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]
Cybersecurity Risk Management Processes Integrated [Text Block]
Net loss
Net Loss
Net loss attributable to common stockholders
Aggregate Intrinsic Value, Outstanding
Aggregate Intrinsic Value, Outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Increase (Decrease) in Inventories
Increase (Decrease) in Inventories, Total
Inventory
Inventory
Inventory [Line Items]
Operating Lease, Cost
Operating lease cost
Expected dividend yield
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Purchase Obligation
Purchase Obligation
Total lease payments
Assets
Assets [Abstract]
2025 Shelf Registration Statement [Member]
Two Thousand And Twenty Five Shelf Registration Statement [Member]
Two Thousand And Twenty Five Shelf Registration Statement [Member]
Research And Development Arrangement [Member]
Research and Development Arrangement [Member]
Risk-free interest rate
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Prepaid expenses and other current assets
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets, Total
Prepaid expenses and other current assets
Document Fiscal Year Focus
Document Fiscal Year Focus
Concentration Risk Benchmark [Domain]
Cash flows from investing activities:
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]
Retirement Benefits [Abstract]
Accounts payable
Accounts Payable, Current
Accounts Payable, Current, Total
Research and Development Expense [Member]
Research and Development [Member]
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]
Marketable Securities
Other non-current assets
Other non-current assets
Increase (Decrease) in Other Noncurrent Assets
Research Tax Credit Carryforward
Research Tax Credit Carryforward [Member]
2025 ATM Prospectus Supplement [Member]
Two Thousand And Twenty Five ATM Prospectus Supplement [Member]
Two Thousand And Twenty Five ATM Prospectus Supplement [Member]
Components of Deferred Tax Assets [Abstract]
Fair Value Measurements
Fair Value Measurement, Policy [Policy Text Block]
Convertible Debt, Total
Convertible Debt
Convertible Debt
2026
Purchase Obligation, to be Paid, Year One
Adintrevimab Research and Development Expense
Amount of expense for research and development allocated to the Adintrevimab program.
Adintrevimab
Lessee, Operating Lease, Total Lease Space
Lessee, operating lease total lease space.
Lease space
Proceeds from Stock Options Exercised
Proceeds from exercises of stock options
Fair Value Disclosures [Abstract]
Commitments and Contingencies Disclosure [Abstract]
Effective Income Tax Rate Reconciliation, Tax Credit, Amount
Effective Income Tax Rate Reconciliation, Tax Credit, Amount, Total
Federal R&D Tax credits, Amount
Federal R&D tax credits, Amount
Effective Income Tax Rate Reconciliation, Cross-Border Tax Effect, Amount [Abstract]
Foreign tax effects
Series B Convertible Preferred Stock [Member]
Series B Convertible Preferred Stock [Member]
Series B Convertible Preferred Stock Member
Stacy Price [Member]
Stacy Price [Member]
Description of income tax benefit
Income Tax Examination, Description
Warrant Expense (Policy)
Warrant Expense (Policy)
Warrant Expense
Debt Instrument [Axis]
Derivative Instrument [Axis]
Share-Based Payment Arrangement [Abstract]
Total unrecognized stock-based compensation cost
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total
Unrecognized stock based compensation expense
Asset fair value disclosure
Assets, Fair Value Disclosure
Assets, Fair Value Disclosure, Total
Accrued external research development and manufacturing expenses.
Accrued External Research Development And Manufacturing Expenses Current
Accrued external research, development and manufacturing costs
Concentration Risk, Percentage
Percentage of total gross revenue
Exercise fee
Exercise Fee
Exercise Fee.
Revenues
Revenues, Total
Revenues
Net cash used in investing activities
Net cash used in investing activities
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Title of 12(b) Security
Title of 12(b) Security
Schedule of Segment Reporting Information, by Segment [Table]
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount
Stock-based compensation, Amount
Forfeited
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Weighted Average Grant Date Fair Value Forfeited
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Annual gross revenue
Annual gross revenue
Annual gross revenue
Money Market Funds
Money Market Funds [Member]
Related Party
Related and Nonrelated Parties [Domain]
Denominator:
Earnings Per Share, Basic, Other Disclosure [Abstract]
Income Taxes
Income Tax Disclosure [Text Block]
Term C Loan [Member]
Term C Loan Member
Term C Loan [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Convertible preferred stock, shares issued
Temporary Equity, Shares Issued
Class of Warrant or Right [Line Items]
Other Liabilities, Noncurrent
Other Liabilities, Noncurrent, Total
Other non-current liability
Percentage of income tax examination likelihood upon ultimate settlement
Percentage of Income Tax Examination Likelihood Upon Ultimate Settlement
Percentage of Income Tax Examination Likelihood Upon Ultimate Settlement.
Drug delivery fees
Drug Delivery Fees
Drug delivery fees
Changes in operating assets and liabilities:
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]
Beginning Balance
Ending Balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Preferred Stock [Text Block]
Convertible Preferred Stock
Accrued professional and consultant fees
Accrued Professional Fees
Prepaid external research, development and manufacturing costs
Prepaid External Research Development And Manufacturing Expense Current
Prepaid external research development and manufacturing expenses.
Income Tax Disclosure [Abstract]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Fair Value, Recurring and Nonrecurring [Table]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Common stock issued in connection with public offering, net
Common Stock Issued in Connection With Public Offering
Common Stock Issued in Connection With Public Offering
Measurement Frequency
Measurement Frequency [Domain]
Income Statement Location
Statement of Income Location, Balance [Axis]
Trading Symbol
Trading Symbol
Property and equipment included in accounts payable
Property and equipment included in accounts payable
Property and equipment included in accounts payable
Adimab Assignment Agreement [Member]
Adimab Assignment Agreement [Member]
Adimab Assignment Agreement.
Schedule Of Related Party Transactions By Related Party [Table]
Related Party Transaction [Table]
Subsequent Event Type [Axis]
Schedule of impact of the adoption [table text block]
Schedule of impact of the adoption [table text block]
Summary of the impact of the adoption
Cash paid for amounts included in the measurement of lease liabilities
Cash flows from financing activities:
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage
Unused Term Loan Commitment Fee Percentage
Expected term (in years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term
Recurring
Fair Value, Recurring [Member]
Accrued Expenses
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
Entity Ex Transition Period
Entity Ex Transition Period
Percentage of Revenue
Percentage of Revenue
Percentage of Revenue
Accrued Interest Receivables [Member]
Accrued Interest Receivables [Member]
Accrued Interest Receivables [Member]
Selling and Marketing Expense
Selling and Marketing Expense, Total
Sales and Marketing costs
Equity Components
Equity Components [Axis]
Total other income, net
Nonoperating Income (Expense)
Equity Component
Equity Component [Domain]
Operating loss carryforwards expiration
Operating Loss Carryforwards Expiration
Expiration date of operating loss carryforward.
Asset Class [Axis]
Pre-funded warrants issued in connection with public offering, net
Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants
Total direct, external research and development expenses by program
Total direct, external research and development expenses by program
Total direct, external research and development expenses by program
Document Annual Report
Document Annual Report
Prepaid Insurance
Prepaid insurance
Machinery and Equipment [Member]
Machinery and Equipment [Member]
Stock Issued During Period, Shares, Employee Stock Purchase Plans
Issuance of common stock under the employee stock purchase plan, shares
Personnel Expense (Research And Development)
Personnel expense
Personnel Expense
Share-based payment award, expiration period
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period
Statement of Comprehensive Income [Abstract]
Pre Funded Warrants [Member]
Pre Funded Warrants [Member]
Pre Funded Warrants [Member]
Maximum [Member]
Maximum [Member]
Statistical Measurement
Statistical Measurement [Axis]
Excercise price per share
Exercised
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Common stock, $0.0001 par value; 1,000,000,000 shares authorized, 281,987,033 shares issued and outstanding at December 31, 2025; 119,835,162 shares issued and outstanding at December 31, 2024
Common Stock Average Price
Common Stock, Value, Issued
Common Stock, Value, Issued, Total
Common Stock, Value, Issued, Beginning Balance
Common Stock, Value, Issued, Ending Balance
Schedule Of Prepaid Expenses And Other Current Assets Table [Text Block]
Tabular disclosure of the carrying amounts of prepaid expenses and other current assets.
Summary of Prepaid Expenses and Other Current Assets
Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs
Capitalized research and development
VBY329
VBY329 Research And Development Expense
VBY329 Research And Development Expense
Net operating loss carryforwards
Deferred Tax Assets, Operating Loss Carryforwards
Deferred Tax Assets, Operating Loss Carryforwards, Total
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
Tax Credit Carryforward
Tax Credit Carryforward [Axis]
Impairment of Long-Lived Assets
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]
Cash and Cash Equivalents [Line Items]
Accrued Liabilities
Accrued expenses
Unrealized (loss) gain, net of tax
Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent, Total
Unrealized loss on available-for-sale securities, net of tax
State income taxes, net of federal benefit
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent
Commission On Sales
Commission On Sales
Commission On Sales
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised
Exercised
Exercised
Entity Public Float
Entity Public Float
Expected volatility
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate
Preferred stock, shares authorized
Preferred Stock, Shares Authorized
Royalty Expense
Royalty expense
Inventory [Domain]
Costs and Expenses
Costs and expenses
Total operating costs and expenses
Finite-Lived Intangible Assets by Major Class
Finite-Lived Intangible Assets by Major Class [Axis]
Royalty Based on Net Sales of Licensed Products, Percentage.
Royalty Based On Net Sales Of Licensed Products Percentage
Royalty Based on Net Sales of Licensed Products, Percentage
Federal agency securities [Member]
Federal agency securities [Member]
Combined voting power on all classes of stock threshold
Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Voting Interests Threshold
share based compensation arrangement by share based payment award percentage of voting interests threshold.
Related Party Transaction [Line Items]
Related Party Transaction [Line Items]
Recognized expense
Business Combination, Separately Recognized Transactions, Expenses and Losses Recognized
Entity Registrant Name
Entity Registrant Name
Unrecognized tax benefits accrued for interest and penalties
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total
Entity Voluntary Filers
Entity Voluntary Filers
Subsequent Events [Abstract]
Cybersecurity Risk Management Positions or Committees Responsible [Flag]
Income Tax Expense (Benefit)
Income tax expense (benefit)
Effective income tax rate, Amount
Effective income tax rate, Amount
Measurement Frequency
Measurement Frequency [Axis]
Available for sale marketable securities
Available for sale marketable securities
Proceeds from issuance of common stock
Proceeds from Issuance of Common Stock
Proceeds from issuance of common stock under the employee stock purchase plan
Cantor Fitzgerald & Co [Member]
Cantor Fitzgerald & Co [Member]
Cantor Fitzgerald & Co [Member]
Security for sale offering
Partners' Capital Account, Public Sale of Units Net of Offering Costs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Distributer Two [Member]
Distributer Two [Member]
Distributer 2
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Concentrations of Credit Risk, Significant Suppliers and License Rights
Concentration Risk, Credit Risk, Policy [Policy Text Block]
Stock-Based Compensation
Compensation Related Costs, Policy [Policy Text Block]
Accumulated other comprehensive loss
Accumulated Other Comprehensive Income (Loss), Net of Tax
Accumulated Other Comprehensive Income (Loss), Net of Tax, Total
Purchases of property and equipment
Purchases of property and equipment
Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Property, Plant, and Equipment, Total
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period
Granted
Non-royalty consideration
Non-Royalty Consideration
Non-Royalty Consideration
Total assets
Assets
Property, Plant and Equipment [Table]
Early-stage programs
Early-Stage Programs Research And Development Expense
Early-Stage Programs Research And Development Expense
Weighted Average Remaining Contractual Term, Exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Retirement Plan Name [Domain]
Cash fee payment per month
Cash fee payment per month
Cash fee payment per month
Effective Income Tax Rate Reconciliation, Cross-Border, Other, Percent
Foreign tax effects, Other
Interest Rate Cap [Member]
Interest Rate Cap [Member]
Other
Other
Other
Operating Lease Future Minimum Payments Receivable Thereafter
Operating Lease Future Minimum Payments Receivable Thereafter
2028 and thereafter
Selling, General and Administrative Expenses [Member]
Selling, general and Administrative Expense [Member]
Issuance of common stock, shares
Stock Issued During Period, Shares, New Issues
Issuance of common stock, net of issuance costs, Shares
Lease, Cost [Abstract]
Lease cost
Convertible preferred stock, shares authorized
Temporary Equity, Shares Authorized
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Vested
Vested
Earnings Per Share, Diluted, Total
Earnings Per Share, Diluted
Net loss per share attributable to common stockholders, diluted
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Schedule of Segment Reported Segment Revenues, and Significant Segment Expenses
Effective Income Tax Rate Reconciliation, Percent [Abstract]
Income Tax Rate Reconciliation
Title and Position [Domain]
City Area Code
City Area Code
VYD Two Hundred Twenty Two DrugSubstance
VYD Two Hundred Twenty Two DrugSubstance [Member]
VYD Two Hundred Twenty Two DrugSubstance [Member]
Auditor Name
PHP Warrant [Member]
PHP Warrant [Member]
PHP Warrant [Member]
Schedule of quarterly financial information
Quarterly Financial Information [Table Text Block]
Counterparty Name [Domain]
Interest Rate Floor [Member]
Interest Rate Floor [Member]
Variable Lease, Cost
Variable lease cost
Stock Issued During Period, Value, Employee Stock Purchase Plan
Proceeds from issuance of common stock under the employee stock purchase plan
Issuance of common stock under the employee stock purchase plan
Operating Lease, Weighted Average Remaining Lease Term
Weighted-average remaining lease
Segment Reporting Information [Line Items]
Lease, Cost
Total lease cost
Total lease cost
Retirement Plan Name [Axis]
Cash Equivalents
Cash and Cash Equivalents, Policy [Policy Text Block]
Property and equipment, net
Property, Plant and Equipment, Net
Property, Plant and Equipment, Net, Ending Balance
Property, Plant and Equipment, Net, Beginning Balance
Property, Plant and Equipment, Net, Total
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability
Operating lease right-of-use asset recognized under ASC 842
A D G20 Drug Substance
A D G20 Drug Substance [Member]
ADG20 Drug Substance [Member]
Loss from operations
Operating Income (Loss)
Loss from operations
Delivery Fee.
Delivery Fee
Delivery fee
Accumulated Deficit [Member]
Retained Earnings [Member]
Cash and Cash Equivalents
Cash and Cash Equivalents [Axis]
Stock-based compensation expense
Share-Based Payment Arrangement, Noncash Expense
Share-based Payment Arrangement, Noncash Expense, Total
Operating Lease, Liability, Noncurrent
Operating lease liabilities, non-current
Operating lease liability
Fair Value Level 1
Fair Value, Inputs, Level 1 [Member]
Net cash provided by financing activities
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Schedule of Operating lease expense
Lease, Cost [Table Text Block]
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent [Abstract]
Nontaxable or nondeductible items:
Auditor Location
Other income:
Nonoperating Income (Expense) [Abstract]
Summary of Marketable Securities
Marketable Securities [Table Text Block]
Derivative Contract [Domain]
Proceeds From Issuance At The Market Offering
Proceeds From Issuance At The Market Offering
Proceeds from at-the-market offering, net of commissions
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Income Tax Authority
Income Tax Jurisdiction [Domain]
Entity Interactive Data Current
Entity Interactive Data Current
Deferred tax liabilities:
Deferred Tax Liabilities, Gross [Abstract]
Income Statement Location
Statement of Income Location, Balance [Domain]
Related party expenses
Costs and Expenses, Related Party
Cash flows from operating activities:
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]
Furniture and Fixtures [Member]
Furniture and Fixtures [Member]
Other non-current liabilities
Increase (Decrease) in Other Noncurrent Liabilities
Outstanding at December 31, 2025
ShareBasedCompensationArrangementByShare Based Payment Award Equity Instruments Other Than Options vested Number
ShareBasedCompensationArrangementByShare Based Payment Award Equity Instruments Other Than Options vested Number
Outstanding at December 31, 2024
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]
Summary of Consolidated Total Gross Revenue
Entity Tax Identification Number
Entity Tax Identification Number
Repurchased common stock, per share
Share Price
Purchase price per share
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
Nature of the Business and Basis of Presentation
PHP [Member]
Population Health Partners [Member]
Population Health Partners [Member]
Local Phone Number
Local Phone Number
Related Party Transaction
Related Party Transaction [Domain]
Other current liability
Other Liabilities, Current
Percentage Of Total Number Of Shares Of Common Stock Outstanding
Percentage of number of shares of common stock outstanding
Percentage Of Total Number Of Shares Of Common Stock Outstanding
Auditor Opinion [Text Block]
Auditor Opinion
2021 Equity Incentive Plan [Member]
Two Thousands Twenty One Equity Incentive Plan [Member]
Two Thousands Twenty One Equity Incentive Plan [Member]
Third Party Logistic Distribution Agent
Third Party Logistic Distribution Agent
Third party logistic distribution agent accounted
Accounting Policies [Abstract]
Schedule of Utility Inventory [Table Text Block]
Inventory
Numerator:
Net Income (Loss) Attributable to Parent [Abstract]
CONNECTICUT
New Haven, Connecticut
Cash and Cash Equivalents [Member]
Cash And Cash Equivalents [Member]
Class of Stock
Class of Stock [Domain]
Shares available for future issuance
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant
Unrecognized stock based compensation expense, Weighted average recognition period
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Entity Emerging Growth Company
Entity Emerging Growth Company
Weighted Average Remaining Contractual Term, Vested and Expected to vest
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term
Tax Credit Carryforward, Name
Tax Credit Carryforward, Name [Domain]